BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rowland KE, Turnidge JD. The impact of penicillin resistance on the outcome of invasive Streptococcus pneumoniae infection in children. Aust N Z J Med 2000;30:441-9. [PMID: 10985508 DOI: 10.1111/j.1445-5994.2000.tb02049.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Raymond J, Bergeret M, Gendrel D. Impact de la résistance bactérienne sur les infections graves. Archives de Pédiatrie 2001;8:697-704. [DOI: 10.1016/s0929-693x(01)80184-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
2 Butler JR, Mcintyre P, Raina Macintyre C, Gilmour R, Howarth AL, Sander B. The cost-effectiveness of pneumococcal conjugate vaccination in Australia. Vaccine 2004;22:1138-49. [DOI: 10.1016/j.vaccine.2003.09.036] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
3 Sirinavin S, Vorachit M, Thakkinstian A, Hongsanguensri S, Wittayawongsruji P. Pediatric invasive pneumococcal disease in a teaching hospital in Bangkok. International Journal of Infectious Diseases 2003;7:183-9. [DOI: 10.1016/s1201-9712(03)90050-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
4 Sader HS, Fritsche TR, Kaniga K, Ge Y, Jones RN. Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains. Antimicrob Agents Chemother 2005;49:3501-12. [PMID: 16048970 DOI: 10.1128/AAC.49.8.3501-3512.2005] [Cited by in Crossref: 110] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
5 Martínez JL, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev 2002;15:647-79. [PMID: 12364374 DOI: 10.1128/CMR.15.4.647-679.2002] [Cited by in Crossref: 306] [Cited by in F6Publishing: 93] [Article Influence: 15.3] [Reference Citation Analysis]
6 Temime L, Guillemot D, Boëlle PY. Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob Agents Chemother 2004;48:2206-13. [PMID: 15155223 DOI: 10.1128/AAC.48.6.2206-2213.2004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
7 Sader HS, Johnson DM, Jones RN. In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci. Antimicrob Agents Chemother 2004;48:53-62. [PMID: 14693518 DOI: 10.1128/AAC.48.1.53-62.2004] [Cited by in Crossref: 65] [Cited by in F6Publishing: 9] [Article Influence: 3.6] [Reference Citation Analysis]
8 Ziglam HM, Finch RG. Penicillin-resistant pneumococci-implications for management of community-acquired pneumonia and meningitis. Int J Infect Dis 2002;6 Suppl 1:S14-20. [PMID: 12044285 DOI: 10.1016/s1201-9712(02)90150-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Turnidge J. Impact of antibiotic resistance on the treatment of sepsis. Scand J Infect Dis 2003;35:677-82. [PMID: 14620154 DOI: 10.1080/00365540310015953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
10 Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y. Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis. 2004;10:1125-1128. [PMID: 15207068 DOI: 10.3201/eid1006.020665] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 3.7] [Reference Citation Analysis]